Patrick S. Davies
Patrick S. Davies is an attorney with the tobacco industry law firm of Covington & Burling. He helped manage the Latin American branch of the Philip Morris-led Whitecoat Project (also known as the environmental tobacco smoke, or ETS Consultants Program) from 1991 to approximately 1994. In 1993-1994, Davies and another Covington & Burling lawyer, John P. Rupp, together managed the tobacco industry's Latin American ETS Consultants Program, an effort to create and maintain doubt about whether secondhand smoke adversely affects the health of nonsmokers.
In 2008, Davies still worked for Covington & Burling in their Washington, D.C. office, although his biosketch on the company web site does not mention any work he did for the tobacco industry.
Davies was born in 1961. He was admitted to bar in the District of Columbia in 1988. He was educated at the University of Scranton, where he received his B.S., summa cum laude, in 1983. He attended the Universidad Catolica de Chile on a Fulbright/ITT International Fellowship from 1983-1984. He attended the University of Notre Dame Law School where he received his J.D., magna cum laude, in 1987. 
Involvement in the tobacco industry's Latin Project
The purpose of Philip Morris and British American Tobacco's Latin Project, also known as the Latin American ETS Consultants Program, was to recruit, train, and deploy a variety of apparently "independent" scientific consultants to "keep the controversy alive" on the subject of secondhand smoke by promoting the tobacco industry's view that debate still existed about whether exposure to secondhand tobacco smoke harms nonsmokers. The Latin Project was a branch of the Philip Morris-led Whitecoat Project. Patrick Davies was closely involved in screening, recruiting and selecting participants for the project.
Once recruited, the consultants were paid retainers and instructed to infuse their opinions about the relative harmlessness of secondhand smoke into popular literature, through seminars, conferences, letters to the editor and media interviews. A goal of the Latin Project was to influence policy makers, media and the public by providing, through industry consultants, "accurate" (pro-industry) information about smoking regulations in public places and workplaces, indoor air quality and ventilation standards, and scientific claims regarding secondhand smoke.
Mr. Davies was involved in recruiting consultants to work in the Latin project, and in coordinating activities designed to boost the prominence of the Latin American consultants in the media. Just prior to, and after a meeting of the Latin American ETS consultants held at the Fontainebleau Hotel in Miami Beach, Florida on February 24-26, 1992, for example, Mr. Davies met with some of the participants to "iron out details relating to possible [Indoor Air Quality] field studies, and other matters.". The industry would secretly fund indoor air-monitoring projects at popular locales like restaurants and workplaces, and the consultants would present the results of the projects at journalist conferences, an arrangement that was designed to "provide the consultants a forum of unsurpassed prestige in the region for introducing the indoor air quality issue to the Latin American media."
In a telltale 1992 letter, Davies describes to Ana Maria Molina of Corporate Affairs for the Ecuadorian tobacco company Tanasa, why it was so important to fund a study by one particular industry consultant named Dr. Jean Raad:
As you know, the object of the Latin America ETS Project is to anticipate and prepare for, rather than simply react to, the arrival of the ETS issue to the region. While it may be true that the issue of the day in Ecuador is advertising, within the next few years -- and, probably, sooner -- ETS can be expected to assume equal or greater importance. When this occurs, the project either already will have been completed or we will have preliminary data that can be used to counter claims by the anti-smoking movement that good indoor air quality and smoking bans go hand in hand.[Italicized emphasis added.]
Davies also describes Dr. Raad as particularly important to the Latin Project because of his prominent position in Ecuador and his access to the media through a newspaper column that he authors. Davies writes that these attributes "could be critical to the success of the ETS project in Ecuador."
Involvement in "Tort Reform" Project
Defense of the tobacco industry
Mr. Davies has defended various entities in the tobacco industry in numerous cases. A partial list:
- Mr. Davies represented the Council for Tobacco Research U.S.A. in the 1998 case of Raymark Industries vs. Brown & Williamson et al, an asbestos case
- Mr. Davies represented the Tobacco Institute in the 2000 case of Association of Washington Public Hospital Districts v. Philip Morris et al. In this case, the Association of Washington Public Hospital Districts (PHD) alleged that the Tobacco Defendants conspired to prevent the PHD from learning that smoking is an addiction that should be treated as a disease, and not merely a bad habit to be kicked, and to deny the PHD the tools to treat this disease, such as smoking cessation products or safer cigarettes.
- Mr. Davies represented the Tobacco Institute when the country of Guatemala sued the U.S. tobacco industry and British American Tobacco in 1998, alleging that the industry engaged in conspiracy, fraud, misrepresentation and other willful misconduct that resulted in expense to the country of Guatemala for treating sick smokers.
Mr. Davies biographical information page on Covington & Burling's Web site fails to mention any of the extensive work he has done for the tobacco industry.
Defense of Pharmaceutical companies
In addition to defending tobacco companies, Mr. Davies represents pharmaceutical companies in civil and criminal cases.
- He coordinated counsel for Purdue Pharma L.P. and associated entities in class action lawsuits filed in federal and state courts around the U.S. by plaintiffs who claimed the incurred personal and economic injuries from using the company’s OxyContin pain relief prescription medication.
- He served as Counsel for Johnson & Johnson/Ortho Biotech, Inc. in False Claims Act litigation involving the anemia drug Procrit.
- He was the attorney for the Consumer Healthcare Products Association, a trade association for the non-prescription drug industry, in numerous lawsuits regarding harm done by over-the-counter medications containing the chemical phenlypropanolamine (PPA) and similar lawsuits involving over-the-counter stimulant laxative products.
Patrick S. Davies, Esq.
Covington & Burling LLP
1201 Pennsylvania Avenue, NW
Washington, DC 20004-2401
Email: pdaviesATcov.com (Replace the word "AT" with an "@" sign)
- ↑ Proctor CJ, Covington & Burling Review of a New Epidemiologic Study of Spousal Smoke Exposure and Lung Cancer Report. November 12, 1991. 5 pp. Philip Morris Bates No. 2063640556/0560
- ↑ Lawyers.com, Covington & Burling Profile Web page accessed March 19, 2008
- ↑ Boyse S, British American Tobacco Note on a Special Meeting of the UK Industry on Environmental Tobacco Smoke, London 880217 Report. February 17, 1988. Philip Morris Bates No. 2063791182/1187
- ↑ Davies PS. Covington & Burling Candidates Selected: Argentina July, 1991. Philip Morris Bates No. 2022889612/9613
- ↑ Davies PS. Covington & Burling. Candidates Not Selected: Argentina July, 1991. Philip Morris Bates No. 2022889614
- ↑ Sebrie, Ernesto M. MD MPH; Barnoya, Joaquin MD MPH; Perez-Stabe, Eliseo MD; Glantz, Stanton A Ph.D., Center for Tobacco Control Research and Education, University of California San FranciscoTobacco Industry Dominating National Tobacco Control Policy Making in Argentina, 1966-2005 Report. September 1, 2005.
- ↑ Covington & Burling Memorandum - Re: Latin America ETS Project Memo/report. March 26, 1992. 5 pp. Philip Morris Bates No. 2503007503/7507
- ↑ Covington & Burling (inferred) Latin American ETS Project: Strategy and Budget Proposal for 940000Report. 1994, 15 pp. Philip Morris Bates No. 2503017246/7260
- ↑ Davies PS, Covington & Burling No title. Letter. 1 pg. May 4, 1992. Philip Morris Bates No. 2500011456/1457
- ↑ Covington & Burling State Tort Reform Project - Lawyer Assignments List. March 6, 1995. Tobacco Institute Bates No. TNWL0040510
- ↑ Bass KN, British American Tobacco; Calvert MJ, Brown & Wiliamson; Davies PS, Covington & Burling et al Raymark Industries, Inc., Plaintiff, v. Brown & Williamson Tobacco Corporation, Defendants. Defendants' Memorandum of Law in Support of Their Motion to Dismiss Jury Trial Demanded Civil Action No. 1:97-CV-2711-RCF Pleading. February 2, 1998. Bates No. 2063335577/5611
- ↑ Berg BJ et al, Association of Washington Public Hospital Districts Association of Washington Public Hospital Districts, Appellant, v. Philip Morris Incorporated, Apellees Pleading. May 1, 2000. Lorillard Bates NO. 98050131/0211
- ↑ Fleming Hovenkamp, Law offices of Howard Rubenstein; Notre Dame; Republic de Guatemala The Republic of Guatemala, Plaintiff, V. The Tobacco Institute, Inc., Defendants. Plaintiff's First Amended Complaint. Civil Action No.98-CV-01185 Pleading. October 30, 1999. Lorillard Bates No. 82332931/2969
- ↑ Biosketch of Patrick S. Davies and his work Accessed March 19, 2008
- ↑ Covington & Burling Web page bio for Patrick S. Davies, Partner, Covington & Burling Accessed March 20, 2008
This article may include information from Tobacco Documents Online.
|Search the Documents Archives of the Tobacco Industry|
|Legacy Tobacco Documents Library:|